
|Videos|November 5, 2018
Immunotherapy Potential in Locally Advanced CSCC
Immunotherapy Potential in Locally Advanced CSCC
Advertisement
A 69-Year-Old Man With Advanced CSCC
- History and physical exam
- An otherwise healthy, 69-year-old male, fair skinned, retired construction worker, widow
- Presented to his PCP with what he described as a wound that was not healing behind his ear; he reported first noticing it at least 6 months ago and complained of recent onset of numbness in the area.
- ECOG PS 1
- The visible, ulcerated lesion was 4.5-cm in diameter and >5-mm deep
- No palpable nodes
- Biopsy confirmed a poorly-differentiated, infiltrative, postauricular cutaneous squamous cell carcinoma lesion with 7-mm invasion into subcutaneous fat.
- The recommended definitive surgical approach involved partial auriculectomy; the patient declined.
- Cemiplimab 3 mg/kg q2w was initiated
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
ASCO 2026 GU Cancer Highlights: Beyond the LBAs
2
FDA Approves Generic Eribulin Mesylate for Metastatic Breast Cancer
3
Dr Cloughesy on Extended Follow-Up Data for Vorasidenib in IDH1/2 Mutant Glioma
4
Long-Term Outcomes Offer Reassurance on Quadruplet Use in Transplant-Ineligible NDMM
5































